Biopharmaceutical company.
FY 2017 MILCON/VA appropriations as it relates to increased appropriations for Viral Hepatitis Testing for VA.

S. 524: Comprehensive Addiction and Recovery Act of 2016 as it relates to Rx take back programs.

Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.

H.R. 6: 21st Century Cures Act.

Education about the value of innovative new medicines.
 
Education about the 340(b) program. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.  

March 2016 CMS proposed rule implementing a new Part B drug payment model.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX